Live healthier, stronger and sharper for longer
Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.
PeptidesRetatrutide and Longevity Biomarkers: A 2026
Retatrutide, a triple GIP/GLP-1/glucagon agonist, is generating significant interest in the longevity field. We examine its effects on critical biomarkers.
PeptidesARA-290 & Longevity Biomarkers: 2026
Exploring ARA-290's influence on crucial longevity biomarkers, this article dissects the evidence behind its potential to modulate inflammation and cellular ageing pathways.
PeptidesDihexa and Longevity Biomarkers: What to Expect
Could Dihexa, a potent hexapeptide, influence key longevity biomarkers? We examine the current preclinical evidence.
PeptidesEpithalon's Impact on Longevity
Epithalon, a synthetic tetrapeptide, garners significant attention for its purported anti-ageing properties. But what does the evidence truly say about its impact on measurable longevity biomarkers?
PeptidesPinealon and Longevity Biomarkers: What the
Pinealon, a tripeptide, is hypothesised to influence longevity pathways. We examine its potential effects on epigenetic clocks, inflammatory markers, and other key biomarkers.
Wondering where to start?
Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.
The Sunday briefing
One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.